Foamix Pharmaceuticals Ltd buy melinda
Start price
28.03.17
/
50%
€4.83
Target price
28.09.17
€8.57
Performance (%)
3.18%
End price
28.09.17
€4.98
Summary
This prediction ended on 28.09.17 with a price of €4.98. With a performance of 3.18%, the BUY prediction by melinda for Foamix Pharmaceuticals Ltd closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Foamix Pharmaceuticals Ltd | 0.000% | 0.000% | -23.757% | -68.435% |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by melinda for this prediction
In the thread Foamix Pharmaceuticals Ltd diskutieren
Akne
Foamix Pharmaceuticals Ltd. in der Entwicklung und Vermarktung von proprietären Schaum Minocyclin zur Behandlung von Akne, Impetigo engagiert und andere Haut conditions.Its Produktportfolios umfassen Schaum Minocyclin, Minocyclin Gel, Schaum Mometason, calcipotriene Schaum, Triamcinolonacetonid.
(Laufzeit überschritten)
Stopped prediction by melinda for Foamix Pharmaceuticals Ltd
Foamix Pharmaceuticals Ltd
Start price
Target price
Perf. (%)
€3.96
10.03.19
10.03.19
€4.87
13.03.20
13.03.20
-30.30%
13.03.20
13.03.20
